Type
- (-) Australian public assessment report (AusPar) (69)
- Cancellation by sponsor (513)
- ARTG (460)
- Prescription medicine registration (44)
- Section 14, TGO91 consent (21)
- Prescription medicine decision summary (19)
- Designation or determination (9)
- Cancellation or suspension (7)
- Prescription medicine evaluation (1)
Sponsor content
69 result(s) found, displaying 21 to 30
-
Australian public assessment report (AusPar)AusPAR for Comirnaty Original/Omicron BA.1 COVID-19 vaccine (tozinameran and riltozinameran) for prevention of COVID-19.
-
Australian public assessment report (AusPar)New AusPAR for Comirnaty (tozinameran) for the prevention of COVID-19 in individuals 6 months of age and older.
-
Australian public assessment report (AusPar)AusPAR for COMIRNATY (tozinameran) for the prevention of COVID-19.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Tozinameran
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Tozinameran
-
Australian public assessment report (AusPar)Australian Public Assessment Report for nirmatrelvir/ritonavir
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Tozinameran (mRNA Covid 19 vaccine)
-
Australian public assessment report (AusPar)Australian Public Assessment Report for BNT162b2 (mRNA)
-
Australian public assessment report (AusPar)Australian Public Assessment Report for BNT162b2 (mRNA)
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Rituximab